Alternative Payment Model

Alternative Payment Model
Name	Alternative Payment Model
Established	2000s
Type	Healthcare payment model
Country	International

Alternative Payment Model

Alternative Payment Model refers to a category of healthcare reimbursement approaches that shift payment away from traditional fee-for-service toward arrangements emphasizing value, outcomes, coordination, and cost control. Developed in response to rising Centers for Medicare & Medicaid Services expenditure and stakeholder pressure from organizations such as American Medical Association and Kaiser Permanente, these models are central to reform discussions involving policymakers, payers, clinical leaders, and health systems like Mayo Clinic and Cleveland Clinic. Early large-scale pilots were launched during administrations and legislative initiatives tied to the Medicare Access and CHIP Reauthorization Act and regulatory efforts by the Department of Health and Human Services.

Overview

Alternative Payment Models (APMs) encompass bundled payments, shared savings, capitated contracts, pay-for-performance, and population-based payments that link reimbursement to measures defined by agencies such as Centers for Medicare & Medicaid Services or standards bodies like National Quality Forum. Stakeholders include health insurers such as UnitedHealth Group and Blue Cross Blue Shield, provider organizations like Johns Hopkins Medicine and Geisinger Health System, and government programs including Medicare and Medicaid. The models aim to align incentives with objectives promoted by international agencies such as the World Health Organization and by national regulators such as National Health Service leadership.

Types and Models

Common types include: - Bundled payment models developed in initiatives led by Centers for Medicare & Medicaid Services Innovation Center and tested by systems like Intermountain Healthcare. - Accountable Care Organizations (ACOs) derived from policy pilots involving Pioneer ACO Model participants and organizations such as Atrius Health. - Pay-for-performance programs implemented by insurers including Aetna and employers like Walmart. - Capitation and global budget arrangements used by integrated systems such as Geisinger Health System and national models in Canada and United Kingdom. - Patient-centered medical home contracts associated with groups like Michigan Primary Care Association and initiatives supported by Robert Wood Johnson Foundation grants.

Implementation and Policy

Implementation commonly requires data sharing, risk adjustment, and quality measurement frameworks coordinated with entities such as National Committee for Quality Assurance and regulators like Centers for Medicare & Medicaid Services. Payment policy levers include waivers, demonstration projects, and legislative acts such as the Affordable Care Act provisions that authorized the Innovation Center. Key implementation challenges have been addressed in guidance from Office of the Inspector General and policy analyses from think tanks like Brookings Institution and The Commonwealth Fund.

Impact on Healthcare Quality and Costs

Evidence from trials and observational studies involving systems such as Kaiser Permanente and Mayo Clinic indicates mixed effects: some APMs show reduced total spending and improved process measures while others produce minimal savings or substitution effects. Evaluations by agencies such as Centers for Medicare & Medicaid Services and researchers at Harvard T.H. Chan School of Public Health and Johns Hopkins Bloomberg School of Public Health assess impacts on readmissions, mortality, and patient experience. International comparisons with programs in Germany, Australia, and Netherlands highlight variation in cost containment and quality outcomes tied to baseline system features and regulatory environments such as those overseen by German Federal Ministry of Health and Australian Commission on Safety and Quality in Health Care.

Payment Design and Incentives

Design elements include risk-sharing percentages, stop-loss provisions, baseline spending benchmarks, and performance metrics tied to standards from National Quality Forum and reporting requirements from Centers for Medicare & Medicaid Services. Incentive structures draw on behavioral economics research by scholars associated with Harvard Kennedy School and Stanford University to mitigate upcoding, patient selection, and service substitution. Payment schedules may incorporate episode-based payments as piloted by Bundled Payments for Care Improvement and global budgets as used in regional pilots such as All-Payer Model (Maryland).

Criticisms and Challenges

Critiques arise from provider groups including American Hospital Association and labor organizations, and from academic commentators at institutions like University of Pennsylvania and Yale School of Medicine. Common concerns include risk selection, administrative burden associated with reporting to entities such as Centers for Medicare & Medicaid Services, potential disparities in access for vulnerable populations represented by advocates like National Association of Community Health Centers, and challenges in attributing outcomes in fragmented markets. Legal and regulatory hurdles include antitrust scrutiny from agencies like the Federal Trade Commission and state-level variations in implementation overseen by departments such as New York State Department of Health.

International Perspectives and Examples

International examples illustrate diverse adaptations: NHS (England) experiments with integrated care models, Canada provinces use global budgets for hospitals such as Alberta Health Services, Germany employs sickness funds and negotiated DRG systems overseen by Federal Joint Committee, and Netherlands utilizes regulated competition among insurers like Achmea and VGZ with bundled contracting. Multi-country studies by organizations including the Organisation for Economic Co-operation and Development and World Health Organization compare metrics across France, Japan, Sweden, and Spain, informing cross-national policy transfer and adaptation.

Category:Health economics